User profiles for Ina Koch
Ina KochProfessor of Bioinformatics, Goethe University Frankfurt am Main Verified email at bioinformatik.uni-frankfurt.de Cited by 17910 |
Prediction of deleterious human alleles
Single nucleotide polymorphisms (SNPs) constitute the bulk of human genetic variation,
occurring with an average density of ∼1/1000 nucleotides of a genotype. SNPs are either …
occurring with an average density of ∼1/1000 nucleotides of a genotype. SNPs are either …
Comprehensive genomic profiles of small cell lung cancer
We have sequenced the genomes of 110 small cell lung cancers (SCLC), one of the deadliest
human cancers. In nearly all the tumours analysed we found bi-allelic inactivation of TP53 …
human cancers. In nearly all the tumours analysed we found bi-allelic inactivation of TP53 …
[PDF][PDF] Complexome profiling identifies TMEM126B as a component of the mitochondrial complex I assembly complex
…, S Dröse, B Schwamb, M Zörnig, AS Reichert, I Koch… - Cell metabolism, 2012 - cell.com
Macromolecular complexes are essential players in numerous biological processes. They
are often large, dynamic, and rather labile; approaches to study them are scarce. Covering …
are often large, dynamic, and rather labile; approaches to study them are scarce. Covering …
Application of Petri net based analysis techniques to signal transduction pathways
Background Signal transduction pathways are usually modelled using classical quantitative
methods, which are based on ordinary differential equations (ODEs). However, some …
methods, which are based on ordinary differential equations (ODEs). However, some …
Whither systems medicine?
New technologies to generate, store and retrieve medical and research data are inducing a
rapid change in clinical and translational research and health care. Systems medicine is the …
rapid change in clinical and translational research and health care. Systems medicine is the …
Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA
I Koch, R Weil, R Wolbold, J Brockmöller… - Drug Metabolism and …, 2002 - ASPET
The elucidation of the individual contributions of the fourCYP3A genes to the overall CYP3A
activity has been hampered by similarities in their sequence and function. We investigated …
activity has been hampered by similarities in their sequence and function. We investigated …
The genetic determinants of the CYP3A5 polymorphism
…, P Neuhaus, J Klattig, R Eiselt, I Koch… - Pharmacogenetics …, 2001 - journals.lww.com
CYP3A proteins comprise a significant portion of the hepatic cytochrome P450 (CYP) protein
and they metabolize aroud 50% of drugs currently in use. The dissection of the individual …
and they metabolize aroud 50% of drugs currently in use. The dissection of the individual …
Enumerating all connected maximal common subgraphs in two graphs
I Koch - Theoretical Computer Science, 2001 - Elsevier
We represent a new method for finding all connected maximal common subgraphs in two
graphs which is based on the transformation of the problem into the clique problem. We have …
graphs which is based on the transformation of the problem into the clique problem. We have …
Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene
…, R Eiselt, E Hustert, H Arnold, I Koch… - Pharmacogenetics …, 2001 - journals.lww.com
Proteins encoded by the human CYP3A genes metabolize every second drug currently in
use. The activity of CYP3A gene products in the general population is highly variable and may …
use. The activity of CYP3A gene products in the general population is highly variable and may …
Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer
…, WK Roth, B Rotter, K Hoffmeier, G Kahl, I Koch… - Molecular cancer, 2015 - Springer
Background Previous studies identified microRNAs (miRNAs) and messenger RNAs with
significantly different expression between normal pancreas and pancreatic cancer (PDAC) …
significantly different expression between normal pancreas and pancreatic cancer (PDAC) …